Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients.

Szczegóły
Pełny tekst

Tytuł:: Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients.
Autorzy:: Farfour E; Service de Biologie Clinique, Hôpital Foch, Suresnes, France.
Trochu E; Service de Biologie Clinique, Hôpital Foch, Suresnes, France.
Devin C; Service de Biologie Clinique, Hôpital Foch, Suresnes, France.
Cardot Martin E; Service de Biologie Clinique, Hôpital Foch, Suresnes, France.
Limousin L; Service de Biologie Clinique, Hôpital Foch, Suresnes, France.
Roux A; Service de Pneumologie, Hôpital Foch, Suresnes, France.
Picard C; Service de Pneumologie, Hôpital Foch, Suresnes, France.
Jolly E; Service de Biologie Clinique, Hôpital Foch, Suresnes, France.
Vasse M; Service de Biologie Clinique, Hôpital Foch, Suresnes, France.
Lesprit P; Service de Biologie Clinique, Hôpital Foch, Suresnes, France.
Źródło:: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2018 Oct; Vol. 20 (5), pp. e12955. Date of Electronic Publication: 2018 Jun 25.
Typ publikacji:: Letter
Język:: English
Imprint Name(s):: Original Publication: Copenhagen : Munksgaard, c1999-
MeSH Terms:: Drug Resistance, Multiple, Bacterial*
Anti-Bacterial Agents/*therapeutic use
Azabicyclo Compounds/*therapeutic use
Bacteria/*drug effects
Ceftazidime/*therapeutic use
Cystic Fibrosis/*drug therapy
Achromobacter/drug effects ; Anti-Bacterial Agents/pharmacology ; Azabicyclo Compounds/pharmacology ; Bacteria/isolation & purification ; Burkholderia cepacia complex/drug effects ; Burkholderia cepacia complex/isolation & purification ; Ceftazidime/pharmacology ; Cystic Fibrosis/epidemiology ; Cystic Fibrosis/microbiology ; Drug Combinations ; Enterobacteriaceae/drug effects ; Enterobacteriaceae/isolation & purification ; Humans ; Microbial Sensitivity Tests ; Pseudomonas aeruginosa/drug effects ; Pseudomonas aeruginosa/isolation & purification ; Stenotrophomonas maltophilia/drug effects ; Stenotrophomonas maltophilia/isolation & purification
Contributed Indexing:: Keywords: Stenotrophomonas maltophilia; Achromobacter spp; Burkholderia spp; ceftazidime avibactam; cystic fibrosis
Substance Nomenclature:: 0 (Anti-Bacterial Agents)
0 (Azabicyclo Compounds)
0 (Drug Combinations)
0 (avibactam, ceftazidime drug combination)
9M416Z9QNR (Ceftazidime)
Entry Date(s):: Date Created: 20180614 Date Completed: 20181227 Latest Revision: 20181227
Update Code:: 20240105
DOI:: 10.1111/tid.12955
PMID:: 29896802
: Opinia redakcyjna

Pełny tekst

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja